This summary was created by AI, based on 1 opinions in the last 12 months.
STAAR Surgical (STAA-Q) has garnered attention from experts due to its technical performance, particularly in the context of the Russell 2000 index. According to Jessica Inskip, this small-cap stock is distinguished by rising moving averages, indicating positive momentum. The stock is currently forming a base, which suggests potential for future growth. If it successfully breaks through the resistance levels around $55 to $60, there is enthusiasm that it could reach a target price of $75. Overall, the outlook appears optimistic as the stock shows signs of strength within the small-cap sector, a notable quality amid the varied performances of its peers.
STAAR Surgical is a American stock, trading under the symbol STAA-Q on the NASDAQ (STAA). It is usually referred to as NASDAQ:STAA or STAA-Q
In the last year, 1 stock analyst published opinions about STAA-Q. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for STAAR Surgical.
STAAR Surgical was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for STAAR Surgical.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of STAAR Surgical published on Stockchase.
On 2025-03-13, STAAR Surgical (STAA-Q) stock closed at a price of $17.41.
The only smallcap in her analysis with rising moving averages and the stock forming a base. If it clears resistance of $55-60, it could hit $75.